Ameriprise Financial Inc Aldeyra Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

  • $381 Billion
  • Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 12,580 shares of ALDX stock, worth $63,654. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,580
Holding current value
$63,654
% of portfolio
0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$3.19 - $6.32 $40,130 - $79,505
12,580 New
12,580 $67,000
Q1 2024

May 15, 2024
SELL
$2.77 - $4.22 $110,113 - $167,753
-39,752 Reduced 23.96%
126,176 $412,000
Q4 2023

Feb 14, 2024
SELL
$1.47 - $6.06 $47,162 - $194,422
-32,083 Reduced 16.2%
165,928 $582,000
Q3 2023

Nov 14, 2023
SELL
$6.11 - $8.16 $33,165 - $44,292
-5,428 Reduced 2.67%
198,011 $1.32 Million
Q2 2023

Aug 14, 2023
BUY
$7.11 - $11.89 $426,649 - $713,483
60,007 Added 41.84%
203,439 $1.71 Million
Q1 2023

May 15, 2023
BUY
$5.77 - $9.93 $18,464 - $31,776
3,200 Added 2.28%
143,432 $1.42 Million
Q4 2022

Feb 14, 2023
BUY
$5.08 - $7.09 $518,322 - $723,406
102,032 Added 267.1%
140,232 $976,000
Q3 2022

Nov 14, 2022
BUY
$3.8 - $7.74 $53,200 - $108,360
14,000 Added 57.85%
38,200 $204,000
Q2 2022

Aug 15, 2022
SELL
$2.43 - $4.85 $16,038 - $32,009
-6,600 Reduced 21.43%
24,200 $97,000
Q4 2021

Feb 14, 2022
SELL
$3.5 - $9.63 $52,850 - $145,413
-15,100 Reduced 32.9%
30,800 $123,000
Q3 2021

Nov 15, 2021
SELL
$7.94 - $11.31 $794 - $1,131
-100 Reduced 0.22%
45,900 $403,000
Q2 2021

Aug 16, 2021
BUY
$10.44 - $14.85 $230,724 - $328,185
22,100 Added 92.47%
46,000 $510,000
Q1 2021

May 17, 2021
SELL
$6.53 - $14.42 $872,786 - $1.93 Million
-133,658 Reduced 84.83%
23,900 $284,000
Q4 2020

Feb 12, 2021
SELL
$6.31 - $8.13 $499,221 - $643,213
-79,116 Reduced 33.43%
157,558 $1.08 Million
Q3 2020

Nov 16, 2020
BUY
$4.0 - $7.53 $872,884 - $1.64 Million
218,221 Added 1182.58%
236,674 $1.75 Million
Q2 2020

Aug 14, 2020
BUY
$1.97 - $5.05 $36,352 - $93,187
18,453 New
18,453 $76,000
Q1 2019

May 15, 2019
SELL
$7.14 - $9.85 $756,604 - $1.04 Million
-105,967 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$7.26 - $13.29 $167,597 - $306,799
23,085 Added 27.85%
105,967 $879,000
Q3 2018

Nov 14, 2018
BUY
$6.8 - $14.35 $563,597 - $1.19 Million
82,882 New
82,882 $1.14 Million

Others Institutions Holding ALDX

# of Institutions
117
Shares Held
36.4M
Call Options Held
196K
Put Options Held
142K
View Full List

About Aldeyra Therapeutics, Inc.

ALDX Quotes by TradingView
  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $295M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email